Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Zimmer Holdings, Inc. : Zimmer Receives FDA Warning on Certain Hip Implants

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/02/2012 | 12:40am CEST

--Zimmer says FDA inspection of Puerto Rico plant turned up concerns about manufacturing of certain implants

--FDA in letter noted manufacturing, testing issues related to Trilogy Acetabuar System products, company says

--Zimmer says it is notifying customers of manufacturing issue, but hasn't withdrawn any products

(Adds context on metallic spikes in fourth paragraph and a no comment from Zimmer in seventh paragraph.)

 
   By Kristin Jones 
 

Zimmer Holdings Inc. (ZMH) said a U.S. Food and Drug Administration inspection of its plant in Puerto Rico turned up concerns about the manufacturing of certain hip implants.

The orthopedic maker's Zimmer Inc. subsidiary received a warning letter from the FDA dated Sept. 19, the company said in a regulatory filing Monday. In the letter, the FDA noted manufacturing and testing issues related to the company's Trilogy Acetabular System products, which are implanted in hip-replacement surgery.

Specifically, the U.S. drug regulator noted that Zimmer hadn't implemented a testing mechanism to show that its products met design specifications. The company also hadn't validated the effect of certain manufacturing operations on Trilogy products that incorporate metallic spikes.

Spikes are used to connect the hip replacement cup to a patient's bone when cement and screws are deemed insufficient.

The FDA requires that drug and medical-device makers undertake steps to ensure the quality of the design and manufacture of its products, known as process validation.

Zimmer said it is notifying customers of the manufacturing issue, but that it hasn't withdrawn any products. The company also said it previously suspended release of the spiked products, pending validation of the processes cited in the letter, and expects to complete validation in the next few weeks.

A Zimmer spokesman declined to comment further.

Shares gained 11 cents to $67.98 in after-hours trading. Through Monday's close, the stock was up 27% so far this year.

--Joseph Walker contributed to this article.

Write to Kristin Jones at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
04/20 ZIMMER BIOMET : Apr 20, 2017 Zimmer Biomet Holdings to Present at 42nd Annual De..
04/11 ZIMMER BIOMET : Apr 11, 2017 Zimmer Biomet Holdings Announces Live Audio Webcast..
03/29 ZIMMER BIOMET HOLDINGS INC : ex-dividend day
03/23 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Departure of Directors or..
03/23 ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers (form 8..
03/23 ZIMMER BIOMET : Showcases New Product Innovation, Novel Digital Health Offering ..
03/21 INSIDER TRADING ACTIVITY ZIMMER BIOM : ZBH) – Insider Sold 1,040 shares of..
03/21 SMITH & NEPHEW : Hip and Knee Orthopedic Surgical Robots Market 2017 - Stryker/M..
03/14 ZIMMER BIOMET : Mar 14, 2017 Zimmer Biomet Showcases New Product Innovation, Nov..
03/04 ZIMMER BIOMET : Today the Zimmer Biomet Holdings, Inc. Position Boosted by Winsl..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
03/31 Investors bet on a quiet tech revolution in Europe
03/30 FTSE ends little changed, support from mining stocks
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
04/10 Top 10 Healthcare Stocks For Dividend Growth And Income
03/21 Northcoast upgrades Wright Medical to Buy amidst takeover speculation at ~$36
03/01 Zimmer Biomet declares $0.24 dividend
02/23 Back To The Future With Wright Medical
02/13 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 87 Increases Expected By April 30
Advertisement
Financials ($)
Sales 2017 7 886 M
EBIT 2017 2 584 M
Net income 2017 1 179 M
Debt 2017 9 249 M
Yield 2017 0,82%
P/E ratio 2017 23,80
P/E ratio 2018 17,49
EV / Sales 2017 4,26x
EV / Sales 2018 3,99x
Capitalization 24 386 M
More Financials
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 135 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Adrian Furey Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS..17.43%24 386
MEDTRONIC PLC12.99%110 168
BAXTER INTERNATIONAL I..19.26%28 659
HOYA CORPORATION4.33%18 336
C R BARD INC12.65%18 300
DENTSPLY SIRONA INC8.31%14 394
More Results